Table 1. Immune Drugs Consumption Value & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Immune Drugs Market Restraints

Table 3. Immune Drugs Market Trends

Table 4. Immune Drugs Industry Policy

Table 5. Global Immune Drugs Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022

Table 6. Global Immune Drugs Revenue Share by Company, 2019-2024, Ranked by Data of 2022

Table 7. Global Immune Drugs Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2022

Table 8. Global Immune Drugs Sales Quantity by Company, 2019-2024, Ranked by Data of 2022

Table 9. Global Immune Drugs Average Selling Price (ASP) by Company, (2019-2024) & (US$/Unit)

Table 10. Global Immune Drugs Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Immune Drugs Mergers & Acquisitions, Expansion Plans

Table 12. Global Immune Drugs Manufacturers Product Type

Table 13. Head Office and Immune Drugs Production Site of Key Manufacturer

Table 14. Immune Drugs Capacity of Major Manufacturers and Future Plan

Table 15. China Immune Drugs Revenue by Company, 2019-2024, US$ million, Ranked Based on Revenue in 2022

Table 16. China Immune Drugs Sales Quantity by Company, (2019-2024) & (K Units), Ranked Based on Sales in 2022

Table 17. China Immune Drugs Sales Quantity by Company, 2019-2024, Ranked by Data of 2022

Table 18. Global Immune Drugs Production & Forecast by Region, 2019 VS 2024 VS 2030, (K Units)

Table 19. Global Immune Drugs Production by Region, 2019-2024, (K Units)

Table 20. Global Immune Drugs Production Forecast by Region, 2024-2029, (K Units)

Table 21. Global Key Players of Immune Drugs Upstream (Raw Materials)

Table 22. Global Immune Drugs Typical Customers

Table 23. Immune Drugs Typical Distributors

Table 24. By Type, Global Immune Drugs Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 25. By Application, Global Immune Drugs Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 26. By Region, Global Immune Drugs Consumption Value, 2019 VS 2024 VS 2030, US$ Million

Table 27. By Region, Global Immune Drugs Consumption Value, 2019-2030, US$ Million

Table 28. By Region, Global Immune Drugs Sales Quantity, 2019-2030, (K Units)

Table 29. By Country, Global Immune Drugs Consumption Value & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 30. By Country, Global Immune Drugs Consumption Value, 2019-2030, US$ Million

Table 31. By Country, Global Immune Drugs Consumption Value Market Share, 2019-2030

Table 32. By Country, Global Immune Drugs Sales Quantity, 2019-2030, (K Units)

Table 33. By Country, Global Immune Drugs Sales Quantity Market Share, 2019-2030

Table 34. Antares Pharma, Inc. Company Information, Head Office, Market Area, and Industry Position

Table 35. Antares Pharma, Inc. Immune Drugs Models, Specifications, and Application

Table 36. Antares Pharma, Inc. Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 37. Antares Pharma, Inc. Company Profile and Main Business

Table 38. Antares Pharma, Inc. Recent Developments

Table 39. UCB Company Information, Head Office, Market Area, and Industry Position

Table 40. UCB Immune Drugs Models, Specifications, and Application

Table 41. UCB Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 42. UCB Company Profile and Main Business

Table 43. UCB Recent Developments

Table 44. Incyte Company Information, Head Office, Market Area, and Industry Position

Table 45. Incyte Immune Drugs Models, Specifications, and Application

Table 46. Incyte Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 47. Incyte Company Profile and Main Business

Table 48. Incyte Recent Developments

Table 49. GSK Company Information, Head Office, Market Area, and Industry Position

Table 50. GSK Immune Drugs Models, Specifications, and Application

Table 51. GSK Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 52. GSK Company Profile and Main Business

Table 53. GSK Recent Developments

Table 54. Takeda Company Information, Head Office, Market Area, and Industry Position

Table 55. Takeda Immune Drugs Models, Specifications, and Application

Table 56. Takeda Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 57. Takeda Company Profile and Main Business

Table 58. Takeda Recent Developments

Table 59. 3S Bio Company Information, Head Office, Market Area, and Industry Position

Table 60. 3S Bio Immune Drugs Models, Specifications, and Application

Table 61. 3S Bio Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 62. 3S Bio Company Profile and Main Business

Table 63. 3S Bio Recent Developments

Table 64. Horizo​​n Therapeutics Company Information, Head Office, Market Area, and Industry Position

Table 65. Horizo​​n Therapeutics Immune Drugs Models, Specifications, and Application

Table 66. Horizo​​n Therapeutics Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 67. Horizo​​n Therapeutics Company Profile and Main Business

Table 68. Horizo​​n Therapeutics Recent Developments

Table 69. Bristol-Myers Squibb (BMS Company Information, Head Office, Market Area, and Industry Position

Table 70. Bristol-Myers Squibb (BMS Immune Drugs Models, Specifications, and Application

Table 71. Bristol-Myers Squibb (BMS Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 72. Bristol-Myers Squibb (BMS Company Profile and Main Business

Table 73. Bristol-Myers Squibb (BMS Recent Developments

Table 74. Astellas Company Information, Head Office, Market Area, and Industry Position

Table 75. Astellas Immune Drugs Models, Specifications, and Application

Table 76. Astellas Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 77. Astellas Company Profile and Main Business

Table 78. Astellas Recent Developments

Table 79. Eli Lilly Company Information, Head Office, Market Area, and Industry Position

Table 80. Eli Lilly Immune Drugs Models, Specifications, and Application

Table 81. Eli Lilly Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 82. Eli Lilly Company Profile and Main Business

Table 83. Eli Lilly Recent Developments

Table 84. Mitsubishi Tanabe Pharma Company Information, Head Office, Market Area, and Industry Position

Table 85. Mitsubishi Tanabe Pharma Immune Drugs Models, Specifications, and Application

Table 86. Mitsubishi Tanabe Pharma Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 87. Mitsubishi Tanabe Pharma Company Profile and Main Business

Table 88. Mitsubishi Tanabe Pharma Recent Developments

Table 89. Biogen Company Information, Head Office, Market Area, and Industry Position

Table 90. Biogen Immune Drugs Models, Specifications, and Application

Table 91. Biogen Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 92. Biogen Company Profile and Main Business

Table 93. Biogen Recent Developments

Table 94. Pfizer Company Information, Head Office, Market Area, and Industry Position

Table 95. Pfizer Immune Drugs Models, Specifications, and Application

Table 96. Pfizer Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 97. Pfizer Company Profile and Main Business

Table 98. Pfizer Recent Developments

Table 99. Sanofi Company Information, Head Office, Market Area, and Industry Position

Table 100. Sanofi Immune Drugs Models, Specifications, and Application

Table 101. Sanofi Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 102. Sanofi Company Profile and Main Business

Table 103. Sanofi Recent Developments

Table 104. Roche Company Information, Head Office, Market Area, and Industry Position

Table 105. Roche Immune Drugs Models, Specifications, and Application

Table 106. Roche Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 107. Roche Company Profile and Main Business

Table 108. Roche Recent Developments

Table 109. Novartis Company Information, Head Office, Market Area, and Industry Position

Table 110. Novartis Immune Drugs Models, Specifications, and Application

Table 111. Novartis Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 112. Novartis Company Profile and Main Business

Table 113. Novartis Recent Developments

Table 114. Johnson & Johnson (J&J) Company Information, Head Office, Market Area, and Industry Position

Table 115. Johnson & Johnson (J&J) Immune Drugs Models, Specifications, and Application

Table 116. Johnson & Johnson (J&J) Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 117. Johnson & Johnson (J&J) Company Profile and Main Business

Table 118. Johnson & Johnson (J&J) Recent Developments

Table 119. Amgen Company Information, Head Office, Market Area, and Industry Position

Table 120. Amgen Immune Drugs Models, Specifications, and Application

Table 121. Amgen Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 122. Amgen Company Profile and Main Business

Table 123. Amgen Recent Developments

Table 124. Abbvi Company Information, Head Office, Market Area, and Industry Position

Table 125. Abbvi Immune Drugs Models, Specifications, and Application

Table 126. Abbvi Immune Drugs Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2024

Table 127. Abbvi Company Profile and Main Business

Table 128. Abbvi Recent Developments

List of Figures

Figure 1. Immune Drugs Picture

Figure 2. Global Immune Drugs Consumption Value, (US$ million) & (2019-2030)

Figure 3. Global Immune Drugs Sales Quantity, (K Units) & (2019-2030)

Figure 4. Global Immune Drugs Average Selling Price (ASP), (2019-2030) & (US$/Unit)

Figure 5. China Immune Drugs Consumption Value, (US$ million) & (2019-2030)

Figure 6. China Immune Drugs Sales Quantity (K Units) & (2019-2030)

Figure 7. China Immune Drugs Average Selling Price (ASP), (US$/Unit) & (2019-2030)

Figure 8. By Consumption Value, China Immune Drugs Market Share of Global, 2019-2030

Figure 9. By Sales Quantity, China Immune Drugs Market Share of Global, 2019-2030

Figure 10. Global Immune Drugs Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022

Figure 11. China Immune Drugs Key Participants, Market Share, 2022

Figure 12. Global Immune Drugs Capacity, Production and Capacity Utilization, 2019-2030

Figure 13. Global Immune Drugs Capacity Market Share by Region, 2022 VS 2029

Figure 14. Global Immune Drugs Production Market Share & Forecast by Region, 2019-2030

Figure 15. Immune Drugs Industry Chain

Figure 16. Immune Drugs Procurement Model

Figure 17. Immune Drugs Sales Model

Figure 18. Immune Drugs Sales Channels, Direct Sales, and Distribution

Figure 19. Immune Boosting Drugs

Figure 20. Immunosuppressant Drugs

Figure 21. By Type, Global Immune Drugs Consumption Value, 2019-2030, US$ Million

Figure 22. By Type, Global Immune Drugs Consumption Value Market Share, 2019-2030

Figure 23. By Type, Global Immune Drugs Sales Quantity, 2019-2030, (K Units)

Figure 24. By Type, Global Immune Drugs Sales Quantity Market Share, 2019-2030

Figure 25. By Type, Global Immune Drugs Average Selling Price (ASP), 2019-2030, (US$/Unit)

Figure 26. Hospital

Figure 27. Clinic

Figure 28. Surgery Center

Figure 29. Others

Figure 30. By Application, Global Immune Drugs Consumption Value, 2019-2030, US$ Million

Figure 31. By Application, Global Immune Drugs Consumption Value Market Share, 2019-2030

Figure 32. By Application, Global Immune Drugs Sales Quantity, 2019-2030, (K Units)

Figure 33. By Application, Global Immune Drugs Sales Quantity Market Share, 2019-2030

Figure 34. By Application, Global Immune Drugs Average Selling Price (ASP), 2019-2030, (US$/Unit)

Figure 35. By Region, Global Immune Drugs Consumption Value Market Share, 2019-2030

Figure 36. By Region, Global Immune Drugs Sales Quantity Market Share, 2019-2030

Figure 37. North America Immune Drugs Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 38. By Country, North America Immune Drugs Consumption Value Market Share, 2022

Figure 39. Europe Immune Drugs Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 40. By Country, Europe Immune Drugs Consumption Value Market Share, 2022

Figure 41. Asia Pacific Immune Drugs Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 42. By Country/Region, Asia Pacific Immune Drugs Consumption Value Market Share, 2022

Figure 43. South America Immune Drugs Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 44. By Country, South America Immune Drugs Consumption Value Market Share, 2022

Figure 45. Middle East & Africa Immune Drugs Consumption Value & Forecasts, 2019-2030, US$ Million

Figure 46. U.S. Immune Drugs Sales Quantity, 2019-2030, (K Units)

Figure 47. By Type, U.S. Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 48. By Application, U.S. Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 49. Europe Immune Drugs Sales Quantity, 2019-2030, (K Units)

Figure 50. By Type, Europe Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 51. By Application, Europe Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 52. China Immune Drugs Sales Quantity, 2019-2030, (K Units)

Figure 53. By Type, China Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 54. By Application, China Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 55. Japan Immune Drugs Sales Quantity, 2019-2030, (K Units)

Figure 56. By Type, Japan Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 57. By Application, Japan Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 58. South Korea Immune Drugs Sales Quantity, 2019-2030, (K Units)

Figure 59. By Type, South Korea Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 60. By Application, South Korea Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 61. Southeast Asia Immune Drugs Sales Quantity, 2019-2030, (K Units)

Figure 62. By Type, Southeast Asia Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 63. By Application, Southeast Asia Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 64. India Immune Drugs Sales Quantity, 2019-2030, (K Units)

Figure 65. By Type, India Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 66. By Application, India Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 67. Middle East & Africa Immune Drugs Sales Quantity, 2019-2030, (K Units)

Figure 68. By Type, Middle East & Africa Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 69. By Application, Middle East & Africa Immune Drugs Sales Quantity Market Share, 2022 VS 2029

Figure 70. Research Methodology

Figure 71. Breakdown of Primary Interviews

Figure 72. Bottom-up and Top-down Approaches

Figure 73. Top-down Approaches